Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models

INTRODUCTION: Modulation of the gamma-secretase enzyme, which reduces the production of the amyloidogenic Aβ(42 )peptide while sparing the production of other Aβ species, is a promising therapeutic approach for the treatment of Alzheimer's disease. Satori has identified a unique class of small...

Descripción completa

Detalles Bibliográficos
Autores principales: Loureiro, Robyn M, Dumin, Jo Ann, McKee, Timothy D, Austin, Wesley F, Fuller, Nathan O, Hubbs, Jed L, Shen, Ruichao, Jonker, Jeff, Ives, Jeff, Bronk, Brian S, Tate, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707052/
https://www.ncbi.nlm.nih.gov/pubmed/23597079
http://dx.doi.org/10.1186/alzrt173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707052/
https://www.ncbi.nlm.nih.gov/pubmed/23597079
http://dx.doi.org/10.1186/alzrt173

Ejemplares similares